The presentation will assist pharmacists in evaluating the most recent guideline update an emerging treatments. This will help pharmacists make recommendations and changes to therapy in line with current evidenced based practices. The purpose of the session is to review recent guideline updates by the American Heart Association/American College of Cardiology. The goal of the session is to augment pharmacist understanding of treatment and management of blood pressure. The knowledge and skills to be gained from the session is utilization of relevant risk calculators to guide treatment, patient education on at home Blood pressure monitoring, and effective management of blood pressure treatment, including medications in the pipeline.

Course Details

Date: Wednesday May 6, 2026
Time: 10:00 am - 11:00 am via webinar
(Webinar will also be available on demand following the event if your schedule does not allow for live viewing.)

Presented by:
Mayela Warner, Pharm.D. • Assistant Professor in the Department of Pharmacy Practice, University of the Incarnate Word Feik School of Pharmacy

CE Credit:
This lesson is a knowledge-based CE activity and is targeted to pharmacists and technicians. This program has been approved for 1.0 contact hours of continuing education credit (0.1 CEU).

• Pharmacists: 0154-0000-26-005-L01-P
• Technicians: 0154-0000-26-005-L01-T

Pricing:
Members: FREE (Log in to your TPA account to receive free CE.)
Non-Members: $25

Learning Objectives:

At the completion of this session, pharmacists will be able to:

1. Given a patient case with either newly diagnosed hypertension, follow-up, or a hypertensive emergency, design a patient-centered plan that incorporates pharmacologic and non-pharmacologic 2025 Hypertension guideline recommendations.
2. Summarize the significant additions to the 2025 Hypertension guideline recommendations.
3. Identify emerging antihypertensive therapies and drugs in the pipeline, and assess their potential role in future patient care. 
   

At the completion of this program, technicians will be able to:

1. Summarize the significant additions to the 2025 Hypertension guideline recommendations.
2. Identify emerging antihypertensive therapies and drugs in the pipeline, and their potential role in future patient care.